Skip to main content
Graduate

MSc in Experimental and Translational Therapeutics

The vision of this course is to provide you with the necessary scientific knowledge to enable you to fully understand the principles that underpin successful translational of novel therapeutics and to apply that to your own professional development. 

Part time

Open
Upcoming application deadline for 2027-28 entry:
12:00 midday UK time on Wednesday 27 January 2027

Expected length
2-4 years
Expected start date
October 2027
English language level
Higher level required

Application deadlines

12:00 midday UK time

Final application deadline for Oxford scholarships

12:00 midday UK time

Expected to be the final application deadline

After the final application deadline has passed, this course may remain open or reopen if places are available.

College buildings and the Radcliffe Camera across a field

About the course

Oxford has made a major contribution to modern molecular medicine and Oxford’s senior scientists have provided significant insights to our understanding of cancer, diabetes, and cardiac, haematological and infectious diseases. There is an opportunity to harness these advances and translate them into therapeutic benefits for patients.

Successful translation of novel therapies requires an interdisciplinary approach and a holistic understanding of the entire drug development pipeline. The MSc in Experimental and Translational Therapeutics draws on the world class research and teaching in experimental therapeutics at the University of Oxford. The course focuses on the underpinning science behind target identification and early development, combined with the art of clinical trial design and practice, with a diverse group of students, each bringing a unique perspective.

The course will appeal to health professionals from a variety of backgrounds, including:

  • qualified doctors
  • specialist registrars in clinical pharmacology or in training for other medical sub-specialities
  • clinical research fellows
  • pharmacists
  • nurses
  • graduates working in the pharmaceutical industry or in academic clinical trials.

Course structure

This section provides an overview of the course structure, while details of the individual course components are provided below.

The MSc is a part-time course consisting of six in-person taught modules and a research dissertation. The modules include, lectures, group work, discussions, guest lectures, interaction and feedback with tutors and lecturers, as well as practical work that develops your knowledge and understanding of the subject.

You must submit a dissertation on a research project that builds on material studied in the taught modules. The project is normally supervised by an academic supervisor from the University of Oxford, which can be combined with an employer-based mentor.

The course is normally completed in two to three years, but up to a maximum of four years may be taken. You will be a full member of the University of Oxford and matriculated as a member of a college.

Core components

You will take six core modules.

Course details

Entry requirements

For entry in 2027-28

Funding and costs

College preference

Before you apply

Completing your application

Contact details